What is the protocol for an MRI perfusion study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MRI Perfusion Study Protocol

The standard MRI perfusion study protocol includes T2-weighted or fluid-attenuated inversion recovery (FLAIR) sequence, diffusion-weighted sequence (DWI), and perfusion-weighted sequence, typically using dynamic susceptibility contrast-enhanced (DSC) T2/T2-weighted MRI with gadolinium-based contrast agent.* 1

Core Components of MRI Perfusion Protocol

Pre-Contrast Sequences

  • T2-weighted or FLAIR sequence to provide anatomical information and identify pathology 1
  • Diffusion-weighted imaging (DWI) to detect cytotoxic edema and assess tissue status 1
  • 3D MR angiography (MRA) of the circle of Willis, either without contrast (time of flight) or with contrast agent 1

Perfusion Sequence

  • Dynamic susceptibility contrast-enhanced (DSC) T2/T2*-weighted MRI is the most common technique 1
  • Requires rapid acquisition of images as a bolus of gadolinium-based contrast agent passes through brain vasculature 2
  • Typically uses a single dose (0.1 mmol/kg) of gadolinium-based contrast agent 3
  • Images must be acquired quickly enough to capture the first pass of the contrast bolus 1

Post-Processing Parameters

  • Cerebral blood volume (CBV): Total volume of blood in a given region 1
  • Cerebral blood flow (CBF): Volume of blood passing through a given region per unit time 1
  • Mean transit time (MTT): Average time for blood to pass through the microvasculature 1
  • Time to peak (TTP): Time from contrast injection to maximum contrast concentration 1

Technical Considerations

Contrast Agent Administration

  • Gadolinium-based contrast agent is injected as a rapid bolus 3, 2
  • For DSC perfusion, a compact bolus is needed for accurate measurements 2
  • If contrast-enhanced MRA is performed, care should be taken to acquire data in the arterial phase to prevent venous opacification 1

Image Acquisition Parameters

  • Echo-planar imaging (EPI) should be used when available 1
  • In case of significant patient motion, radial acquisition schemes may be used (BLADE, PROPELLER, MultiVane, etc.) 1
  • Recommended slice thickness: 3mm with no interslice gap at 3T; up to 4mm with no interslice gap at 1.5T 1

Clinical Applications

Acute Stroke Assessment

  • Perfusion MRI can identify ischemic penumbra (potentially salvageable tissue) 1
  • Perfusion/diffusion mismatch pattern indicates tissue at risk but potentially salvageable 1
  • Typical pattern of collateral flow: lower peak, delayed TTP, increased MTT, decreased flow, normal or elevated CBF 1
  • Typical pattern of absent collateral flow: decreased CBV (poor prognosis) 1

Brain Tumor Evaluation

  • Standardized Brain Tumor Imaging Protocol (BTIP) includes DSC perfusion parameters 1
  • Useful for differentiating tumor progression from pseudoprogression 1
  • DSC-MRI has demonstrated 90% sensitivity and 88% specificity in differentiating true progression from pseudoprogression 1

Common Pitfalls and Limitations

  • Lengthy examination time (30-45 minutes) can be challenging for acutely ill patients, though stroke-specific protocols can reduce this to 15-20 minutes 1
  • Closed MRI environment makes patient monitoring difficult 1
  • Quantification of DSC imaging requires robust determination of arterial input function (AIF) 1
  • No standardization between MR machines, even of the same field strength, limiting comparison of objective parameters between sites 1
  • Bevacizumab therapy affects DSC-MRI-derived rCBV values, which must be considered in patients undergoing this treatment 1
  • Gadolinium-based contrast agents should be avoided in patients with advanced renal failure (estimated glomerular filtration rate <30 mL/min/1.73 m²) due to risk of nephrogenic systemic fibrosis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.